UKRI translation: MRC proof of concept: stage two
Ref: GRT-8S4JF38C
Funding Available
No funding limit (Total fund: £10,000,000)
UK Wide
Life Sciences & Health
4 November 2026
Grants & Funding
About This Grant
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions across any stage of the developmental pathway, from prototype development, through pre-clinical refinement, to early-phase clinical studies (up to phase 2a).
What Can It Fund?
- Prototype development
- Pre-clinical refinement
- Early-phase clinical studies
Eligible Costs
- -Full economic cost (80% funded)
Funding Source
Medical Research Council (MRC)/UKRI
Explore More
Similar Grants
Knowledge Transfer Partnership
Knowledge Transfer Partnerships (KTP) are open to businesses, research organisations, and graduates to work on an innovation project. Partnerships last between 12 and 36 months, with funding provided to support the total cost of the project.
UK-Switzerland CR&D Round 3
Enhance UK and Swiss collaborations and capabilities in emerging technology fields (Semiconductors, Life Sciences, or Engineering Biology), resulting in the development and delivery of new innovations and applications across a broad range of sectors.
Scaling performance of quantum computing hardware: CR&D
Innovate UK will invest up to £33 million to support the development and production readiness of quantum computing hardware device technologies, solving critical system development challenges in hardware and associated software required for universal fault tolerant quantum computing platforms.